This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Perseus Proteomics Inc., The University of Tokyo. Active years: 2013-2015.
Company Filing History:
2 out of 26 
2 out of 1,352 
Years Active: 2013-2015
Title: Aya Sakamoto: Innovator in Antibody Research
Introduction
Aya Sakamoto is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of antibody research, particularly in the development of highly effective anti-cadherin antibodies. With a total of 2 patents, her work is paving the way for advancements in antibody-dependent cellular cytotoxicity.
Latest Patents
Sakamoto's latest patents focus on the creation of anti-cadherin antibodies that exhibit high antibody-dependent cellular cytotoxicity. The first patent describes an anti-cadherin antibody that recognizes specific regions of cadherin domains, achieving an antibody-dependent cellular cytotoxicity of 30% or more at a concentration of 1 µg/mL. This innovation holds promise for enhancing therapeutic strategies in cancer treatment.
Career Highlights
Throughout her career, Aya Sakamoto has worked with esteemed institutions such as The University of Tokyo and Perseus Proteomics Inc. Her research has been instrumental in advancing the understanding of antibody interactions and their applications in medical science.
Collaborations
Sakamoto has collaborated with notable colleagues, including Hiroyuki Aburatani and Lilin Zhang. These partnerships have contributed to her innovative research and the successful development of her patented technologies.
Conclusion
Aya Sakamoto is a trailblazer in the field of antibody research, with her innovative patents and collaborations marking her as a key figure in advancing medical science. Her work continues to inspire future developments in antibody therapies.